PREOP CARDIAC EVALUATION FOR NONCARDIAC SURGERY - PowerPoint PPT Presentation

1 / 58
About This Presentation
Title:

PREOP CARDIAC EVALUATION FOR NONCARDIAC SURGERY

Description:

PREOP CARDIAC EVALUATION FOR NONCARDIAC SURGERY Yatish B. Merchant, MD, FACC Cardiology, New Jersey USA * * * Atenolol given for only 7 days. Why such prolonged ... – PowerPoint PPT presentation

Number of Views:1567
Avg rating:3.0/5.0
Slides: 59
Provided by: wfdSssih
Category:

less

Transcript and Presenter's Notes

Title: PREOP CARDIAC EVALUATION FOR NONCARDIAC SURGERY


1
PREOP CARDIAC EVALUATION FOR NONCARDIAC SURGERY
  • Yatish B. Merchant, MD, FACC
  • Cardiology, New Jersey
  • USA

2
Ultimate Goal
  • Quality of care and serving the patients best
    interests.

3
Goals
  • Understand how to estimate peri-operative CV risk
  • Know when to perform stress testing
    preoperatively
  • Learn how to reduce risk perioperatively in those
    at higher risk

4
55 Years old man with history of hypertension
CAD but asymptomatic runs for 30 minutes daily,
needs inguinal hernia repair. You are consulted
to clear him for surgery.
  • 1) Order Nuclear stress test to evaluate CAD.
  • 2) Order Regular stress test
  • 3) Order Cardiac catheterization
  • 4) Clear for surgery

5
Triggers
  • Surgical Trauma
  • Anesthesia/analgesia
  • Intubation/extubation
  • Pain
  • Hypothermia
  • Bleeding/anemia
  • Fasting
  • Anesthesia/analgesia
  • Hypothermia
  • Bleeding/anemia
  • Surgical Trauma
  • Anesthesia/analgesia
  • Surgical Trauma
  • Anesthesia/analgesia

Hypercoagulable State
?TNF-a ?IL-1 ?IL-6 ?CRP
? catecholamine and cortisol levels
? PAI-1 ? Factor VII ? Platelet reactivity ?
antithrombin III
?oxygen delivery
? BP ? HR ? FFAs ? relative insulin deficiency
Coronary artery shear stress
Plaque fissuring
Plaque fissuring
? Oxygen demand
Myocardial Ischemia
Acute Coronary Thrombus
Perioperative Myocardial Infarction
6
Overview
  • Risk Assessment
  • Preoperative Testing
  • Postoperative Management to Reduce Risk

7
(No Transcript)
8
Approaches to Risk Assessment
  • ASA/Dripps
  • Goldman Multifactorial Index
  • Detsky Modified Index
  • Revised Risk Index
  • ACC/AHA Task Force Recommendations

Quantitative
Strategic
9
Dripps/ASA Classification
10
Goldman Risk Index
Ref Goldman M, Caldera D, Southwick, et al
Multifactorial index of cardiac risk in
non-cardiac surgical procedures. N Engl J Med
1482120-2127, 1988.
11
Goldman Risk Index
Ref Goldman M, Caldera D, Southwick, et al
Multifactorial index of cardiac risk in
non-cardiac surgical procedures. N Engl J Med
1482120-2127, 1988.
12
ACC/AHA Guidelines
J Am Coll Cardiol, 2007 501707-1732
13
Stepwise Approach to the Pre-operative Evaluation
14
Stepwise Approach to Preoperative Cardiac
Assessment
Vigilant perioperative and postoperative
management
Need for emergencynoncardiacsurgery
Operating room
Yes
No
Evaluate and treatper ACC/AHA Guidelines
Active cardiac conditions
Consider Operating Room
Yes
No
Proceed withplanned surgery
Low RiskSurgery
Yes
No
Asymptomatic andgood functionalcapacity
Proceed withplanned surgery
Yes
Manage based onclinical risk factors
No
15
Active Cardiac Conditions
High Risk
  • Acute or recent MI (7-30 d)
  • Unstable coronary syndrome
  • Decompensated CHF
  • Significant Arrhythmias
  • Severe Valvular Disease

Surgery
16
Stepwise Approach to Preoperative Cardiac
Assessment
Vigilant perioperative and postoperative
management
Need for emergencynoncardiacsurgery
Operating room
Yes
No
Evaluate and treatper ACC/AHA Guidelines
Active cardiac conditions
Consider Operating Room
Yes
No
Proceed withplanned surgery
Low RiskSurgery
Yes
No
Asymptomatic andgood functionalcapacity
Proceed withplanned surgery
Yes
Manage based onclinical risk factors
No
17
Low Risk Surgery Risk lt 1
  • Endoscopic procedures
  • Superficial procedure
  • Cataract surgery
  • Breast surgery

18
Low Risk Situations
Low Risk
  • Low risk surgery
  • Good functional capacity
  • No cardiac symptoms
  • No active cardiac conditions
  • No clinical risk factors

Reasonable to proceed with surgery
19
Functional Capacity
Metabolic Equivalents (METs)
  • Correlates with maximum oxygen uptake on
    treadmill testing
  • Demonstrated predictor of future cardiac events
  • Poor functional capacity may hide low threshold
    cardiac symptoms

20
What is basal O2 consumption (Vo2)?
  • 1.5 ml/kg/min
  • 2.5 ml/kg/min
  • 3.5 ml/kg/min
  • 4.5 ml/kg/min

21
Duke Activity Status Index
  • 1 MET Can you take care of yourself?
  • Eat, dress, or use the toilet?
  • Walk indoors around the house?
  • Walk a block or two on level ground at 2-3 mph
    or 3.2-4.8 km/h?
  • 4 METs Do light work around the house like
    dusting or washing clothes?
  • MET metabolic equivalent
  • 4 METs Climb a flight of stairs or walk up a
    hill?
  • Walk on level ground at 4 mph or 6.4 km/h?
  • Run a short distance?
  • Do heavy work around the house like scrubbing
    floors or lifting or moving heavy objects?
  • Participate in moderate recreational activities
    like golf, bowling, dancing, doubles tennis, or
    throwing a baseball or football?
  • 10 METs Participate in strenuous sports like
    swimming, singles tennis, football, baseball, or
    skiing?

Resting or basal O2 consumption(Vo2) of a 70 kg,
40 yrs old man is 3.5 mL per kg per min, or 1 MET.
22
Clinical Risk Factors
  • Known Ischemic Heart Disease
  • Compensated or Prior Heart Failure
  • Diabetes
  • Renal Insufficiency
  • Cerebrovascular disease

23
Stepwise Approach to Preoperative Cardiac
Assessment
Vigilant perioperative and postoperative
management
Need for emergencynoncardiacsurgery
Operating room
Yes
No
Evaluate and treatper ACC/AHA Guidelines
Active cardiac conditions
Consider Operating Room
Yes
No
Proceed withplanned surgery
Low RiskSurgery
Yes
No
Asymptomatic andgood functionalcapacity
Proceed withplanned surgery
Yes
Manage based onclinical risk factors
No
24
Clinical Risk Factors
  • History of heart disease
  • Compensated or prior CHF
  • Cerebrovascular disease
  • Diabetes Mellitus
  • Renal Insufficiency

Proceed Cautiously
25
Asymptomatic butpoor/unknown functionalcapacity
Manage based onclinical risk factors
3 or more clinical risk factors
1 or 2 clinical risk factors
No clinical risk factors
Vascular Surgery
Intermediate risk surgery
Vascular Surgery
Intermediate risk surgery
Proceed withplanned surgery
Proceed with planned surgery with HR controlor
consider non-invasive testing
Consider Testing
Clinical risk factors known ischemic heart
disease, compensated or prior HF, diabetes, renal
insufficiency, cerebrovascular disease
26
Intermediate Risk Surgery Risk lt 5
Carotid endarterectomy Endovascular AAA
repair Head and neck Intraperitoneal and
intrathoracic Orthopedic Prostate
27
High Risk Surgery Risk gt 5
  • Emergent major operations (3-5 times more risk)
  • Aortic and other major vascular
  • Peripheral vascular
  • Anticipated prolonged or associated with large
    fluid shifts and/or blood loss

28
Overview
  • Risk Assessment
  • Preoperative Testing
  • Postoperative Management to Reduce Risk

29
Most preoperative testing assesses for presence
of obstructive CAD and NOT plaque vulnerability
which truly predicts the risk.
Unfortunately we have no way of predicting this.
30
ACC/AHA Recommendations
  • Echocardiography
  • Dyspnea of unknown origin (Class IIa)
  • Current or hx of HF and no echo in 12 months
    (Class IIa)
  • 12 Lead ECG
  • Vascular surgery and 1 CRF (class I)
  • CRFs and intermediate risk surgery (class I)
  • All vascular surgery (class IIa)

31
ACC/AHA Recommendations
  • Treadmill stress testing
  • High cardiac risk conditions
  • 3 CRFs, poor functional capacity vascular
    surgery (class IIa)
  • Nuclear stress testing

32
Which test to choose?
Most ambulatory patients
Treadmill Stress Test
Abnormal resting ECG (dig, LVH)
Exercise echo or sestamibi
LBBB
DSEAdenosine sestamibi dipyridamole sestamibi
Unable to exercise
33
Preoperative TestingNegative Predictive Value
Freedom from MI or Death
Eagle et al. JACC 199627910.
34
Preoperative Testing
Caveats
  • Whenever feasible, an exercise stress test is
    best choice
  • Dipyridamole or adenosine perfusion scan and DSE
    are reasonable choices if
  • unable to exercise
  • BBB or other resting ECG abnormality
  • Avoid dipyridamole and adenosine scan if
    bronchspasm
  • Avoid DSE if serious arrhythmias or severe
    hypertension

35
Overview
  • Risk Assessment
  • Preoperative Testing
  • Perioperative Management to Reduce Risk

36
60 yrs old man with history of CAD, HTN, DM
Creatinine of 2.5 showed small I W ischemia on
nuclear stress test at 10 METS asymptomatic,
needs to have prostatectomy for Ca. How
would you treat?
  • Cardiac cath PCI as indicated.
  • Cancel surgery request other Rx option.
  • BB with heart rate control perioperative.
  • Give nitrates CCB proceed with surgery.

37
Perioperative Nitrates?
Dodds, et al. Anesth. Analg. 199376705-13
38
Perioperative Management
  • Revascularization
  • Beta blockers
  • Statins
  • Alpha-2 agonists
  • Calcium channel blockers

39
Revascularization
  • 5859 vets screened prior to vascular surgery4669
    excluded
  • 510 randomized to
  • Revascularization (258)
  • 99 CABG
  • 141 PCI
  • 18 not revascularized
  • 252 no revascularization
  • 9 revascularized
  • 143 medical rx

McFalls, et al. NEJM 20043512795-2804
40
Intervention is rarely necessary to simply lower
the risk of surgery. Revascularization (surgery
or PCI) should be considered only if standard
indications are present.
41
PCI before anticipated surgery
Acute MIHigh Risk ACSHigh risk anatomy
Bleeding risk of anticipated surgery
Stent and continued Dual-antiplatelet rx
Low
Not low
14 to 29 Days
30 365 Days
gt 365 Days
Balloon angioplasty
Bare-metalstent
Drug-elutingstent
42
Timing of Surgery After PCI
Balloon angioplasty
Bare-metalstent
Drug-elutingstent
lt 14 days
gt 14 days
lt 30-45 days
gt 30-45 days
lt 365 days
gt 365 days
Delay
Surgery with ASA
Delay
Delay
Surgery with ASA
Surgery with ASA
43
Perioperative Management
  • Revascularization
  • Beta blockers
  • Statins
  • Alpha-2 agonists
  • Calcium channel blockers

44
Postoperative Mortality ReductionBeta-Blockers
  • 200 pts undergoing non-cardiac surgery
  • Random assignment to
  • IV followed by oral atenolol or
  • Placebo
  • Double-blind follow-up over 2 years

Mortality
Mangano, et al. NEMJ 19963351713.
45
Postoperative Cardiac Events In High Risk
Patients
  • 173 patients undergoing vascular surgery with
    positive DSE
  • Randomized to BB 1 week pre-op or placebo
  • Followed for 30 days

Bisoprolol n59
Placebo n53
Poldermans et al. NEJM 19993411789.
46
Perioperative Beta Blockers
AHA/ACC Recommendations 2006 Update
  • Beta blockers required in recent past to control
    symptoms of angina or patients with symptomatic
    arrhythmias or hypertension
  • Patients at high cardiac risk owing to the
    finding of ischemia on preoperative testing who
    are undergoing vascular surgery
  • Patients undergoing vascular surgery and with
    identified CAD
  • Vascular surgery and multiple cardiac risk
    factors
  • Moderate or high risk surgery and multiple
    cardiac risk factors

Key Point if known or suspected CAD and
undergoing moderate or high risk surgery, use a
beta blocker!
47
Perioperative Management
  • Revascularization
  • Beta blockers
  • Statins
  • Alpha-2 agonists
  • Calcium channel blockers

48
Perioperative Statins?
  • 100 patients pre-op before vascular surgery
  • Random assignment
  • Atorvastatin 20 mg
  • Placebo
  • Started 30 days preoperatively
  • Follow-up 6 month
  • Endpoint
  • Cardiac death
  • Non-fatal MI
  • USA
  • Stroke

J Vasc. Surgery 200439967
49
Perioperative Statins
Hindler, et al. Anesthesiology 20061051260-72
50
Perioperative Statins
  • 44 reduction in mortality after all types of
    surgery.
  • 59 after vascular surgery alone

Hindler, et al. Anesthesiology 20061051260-72
51
Perioperative Management
  • Revascularization
  • Beta blockers
  • Statins
  • Alpha-2 agonists
  • Calcium channel blockers

52
Perioperative Alpha-2 Agonists
  • Clonidine prophylaxis in patients with or at risk
    of CAD undergoing noncardiac surgery reduced
    perioperative ischemia significantly. (P0.01)
    mortality up to 2 yrs was also reduced (P0.035)

  • Wallace et al (PDBT)

53
Perioperative Management
  • Revascularization
  • Beta blockers
  • Statins
  • Alpha-2 agonists
  • Calcium channel blockers

54
Preoperative Hgb and Mortality
Study of Untreated Anemia
Carson, et al. Lancet. 19963481055-60
55
Perioperative Hypothermia
  • 300 pts undergoing general surgery
  • Randomized, double blinded assignment to routine
    care or supplemental warming

Frank SM JAMA 1997227(14)
56
Triggers
  • Surgical Trauma
  • Anesthesia/analgesia
  • Intubation/extubation
  • Pain
  • Hypothermia
  • Bleeding/anemia
  • Fasting
  • Anesthesia/analgesia
  • Hypothermia
  • Bleeding/anemia
  • Surgical Trauma
  • Anesthesia/analgesia
  • Surgical Trauma
  • Anesthesia/analgesia

Hypercoagulable State
?TNF-a ?IL-1 ?IL-6 ?CRP
? catecholamine and cortisol levels
? PAI-1 ? Factor VII ? Platelet reactivity ?
antithrombin III
?oxygen delivery
? BP ? HR ? FFAs ? relative insulin deficiency
Coronary artery shear stress
Plaque fissuring
Plaque fissuring
? Oxygen demand
Myocardial Ischemia
Acute Coronary Thrombus
Perioperative Myocardial Infarction
57
Key Point
Avoid Sympathetic Stimulation in those at Risk!
  • Beta blocker if able
  • Limit hypothermia
  • Aggressive post-operative pain control
  • Avoid significant anemia

58
THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com